Blood products for hemophilia: past, present and future

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Paul L F Giangrande

Abstract

Hemophilia is an inherited bleeding disorder, which in its severe form is characterized by recurrent hemarthrosis and internal bleeding. In the absence of effective treatment the prognosis is poor, but the development of blood products in the last few decades has transformed the outlook, and patients can now live essentially normal lives. Treatment options vary around the world, with cryoprecipitate still the mainstay of therapy in many developing countries. Many patients were infected with hepatitis and/or HIV through the use of coagulation factor concentrates before the introduction of physical methods of viral inactivation in the mid-1980s. In more affluent countries, the debate in recent years has focused on the relative merits of plasma versus recombinant products. Coagulation factor concentrates are expensive, and cost-benefit and quality-of-life studies will assume an increasing importance in guiding the selection of products. Looking to the future, genetic engineering offers the potential to create coagulation factors with enhanced properties, such as reduced immunogenicity and prolonged half-life. Transgenic animals are a potential source of therapeutic materials. Several trials of gene therapy for hemophilia are alrea...Continue Reading

References

Nov 1, 1990·American Journal of Hematology·M G Conlan, W K Hoots
Jan 28, 1989·BMJ : British Medical Journal·C SmitE Briët
Jan 23, 1988·Lancet·A M Costello
Apr 1, 1985·British Journal of Haematology·S A Larsson
Dec 30, 1965·The New England Journal of Medicine·J G Pool, A E Shannon
Apr 10, 1981·JAMA : the Journal of the American Medical Association·J H Fuerth, P Mahrer
May 1, 1996·British Journal of Haematology·T T YeeC A Lee
Jun 1, 1996·Baillière's Clinical Haematology·D B Brettler
Oct 23, 1997·Nature Biotechnology·R K PaleyandaH Lubon
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S W Pipe, R J Kaufman
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·T W BarrowcliffeA R Hubbard
Jan 5, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·M MikaelssonH Sandberg
Jul 30, 1999·Transfusion Medicine Reviews·A AzziP M Mannucci
Aug 12, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·I ScharrerO Neutzling
Dec 3, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·B L EvattN De Bosch
Dec 22, 1999·Genetic Analysis : Biomolecular Engineering·A Colman
Jan 29, 2000·Journal of Immunological Methods·D P PollockH M Meade
Jun 9, 2001·The New England Journal of Medicine·D A RothUNKNOWN Factor VIII Transkaryotic Therapy Study Group
Jul 10, 2001·Haemophilia : the Official Journal of the World Federation of Hemophilia·E P Mauser-BunschotenH M van den Berg
Mar 12, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·S RoyalUNKNOWN European haemophilia economics study group
Mar 29, 2002·British Journal of Haematology·Anthony R HubbardSally A Bevan
May 16, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·A Farrugia
Oct 22, 2002·The Journal of General Virology·Nora HunterFiona Houston
Dec 5, 2002·International Journal of Hematology·Katherine A High
Jan 30, 2003·Current Gene Therapy·Evgueni L SaenkoRobert G Hawley
Feb 1, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·UNKNOWN United Kingdom Haemophelia Centre Doctors' Organisation
Feb 1, 2003·Haemophilia : the Official Journal of the World Federation of Hemophilia·T Burnouf, M Radosevich
Mar 29, 2003·Transfusion·Jeanne V LindenRichard A Lipton
May 30, 2003·Biology of Reproduction·Jang-Won LeeXiangzhong Yang
Jun 5, 2003·Lancet·Paula H B Bolton-Maggs, K John Pasi

❮ Previous
Next ❯

Citations

Sep 18, 2007·The Journal of Gene Medicine·Jianping WenGonzalo Hortelano
May 26, 2006·Pediatric Blood & Cancer·Leonard A Valentino, Veeral M Oza
Jul 11, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·A SrivastavaUNKNOWN Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia
May 29, 2018·Annual Review of Nutrition·Sydney E ScottPaul Rozin
Dec 7, 2016·International Journal of Technology Assessment in Health Care·Héctor Eduardo Castro JaramilloAurelio E Mejia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Haemophilia : the Official Journal of the World Federation of Hemophilia
G YoungD J Nugent
Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
F VelardiF Stoppa
Seminars in Hematology
Jerrold H Levy
Haemophilia : the Official Journal of the World Federation of Hemophilia
A Van DammeT VandenDriessche
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
P VersuraR Caramazza
© 2022 Meta ULC. All rights reserved